Medical Marijuana, Inc., the parent company of Kannaway and other innovative hemp-based companies, has announced that it once again set company sales revenue records in Q3.
Medical Marijuana, Inc.’s Q3 2018 revenue exceeded $16.8 million dollars, an increase of more than 116% over Q3 2017. Gross profit for Q3 2018 increased nearly 140% over Q3 2017. This announcement continues on a trend of successful growth for Medical Marijuana, Inc. and its portfolio of companies, including Kannaway.
Gross profit for the company for the nine-months ending September 30, 2018 increased nearly 140% over the prior year nine-month period. Revenue for the nine-month period ending September 30, 2018 exceeded $42.1 million dollars, an increase of 146% over the prior year nine-month period.
Kannaway contributed to Medical Marijuana, Inc.’s success in Q3 through a number of initiatives that added to our own trend of upward growth.
In Q3, Kannaway hosted exclusive Premium Humulus Oil training with its active ingredient creator Dr. Bomi Joseph. Premium Humulus Oil is crafted with a patented extract of the hops plant, making it the first non-cannabis source of CBD available to consumers.
In preparation of our Europe Grand Opening Event in November, Kannaway hosted a series of regional events as part of our tour across Europe, hitting cities like Copenhagen, Oslo, Bremen, Milan, Rome, and more.